Fang Wang
Research Subjects
Fang Wang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Baixiang Wang
Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University Hangzhou China
1 shared publication - Feihong Gan
Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University Hangzhou China
1 shared publication - Jiakang Yang
Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University Hangzhou China
1 shared publication - Katong Lo
Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University Hangzhou China
1 shared publication - Kexin Yang
Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University Hangzhou China
1 shared publication - Wenjun Duan
Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University Hangzhou China
1 shared publication
Latest Publications
- 21 April 2026
- Published by Wiley in Clinical Implant Dentistry and Related Research
- Vol. 28 (2) , e70150
Stepwise Modified Transcrestal Sinus Floor Elevation in Sites With 3–5‐mm Residual Bone Height: A Retrospective Study
Objectives: This retrospective study compared the clinical and radiographic outcomes of a stepwise modified transcrestal sinus floor elevation (SM‐TSFE) with the lateral sinus floor elevation (LSFE) for simultaneous implant placement in sites with 3–5 mm of residual bone height (RBH). Materials and Methods: A total of 149 patients with 3–5‐mm RBH underwent simultaneous implant placement using either SM‐TSFE ( n = 69) or LSFE ( n = 80). The follow‐up period ranged from 6 months to 8 years. Evaluated clinical outcomes included implant survival rates, sinus membrane perforation, and postoperative complications. Radiographic assessments included preoperative RBH, marginal bone loss (MBL), and vertical bone height changes. Results: Cumulative implant survival rates were comparable between SM‐TSFE (91.30%) and LSFE (93.75%) groups ( p = 0.537). However, the SM‐TSFE group demonstrated a significantly lower sinus membrane perforation rate (7.24%) compared to the LSFE group (18.75%; p = 0.047). Multivariate analysis identified maxillary sinus septa as the strongest risk factor for perforation ( p = 0.002). Regarding implant failure, TiUnite surface ( p = 0.035) and membrane perforation ( p = 0.039) were significant risk factors, while higher marginal bone height (MBH) was identified as a protective factor ( p = 0.003). Both groups exhibited comparable MBL at 2 years post‐loading ( p > 0.05). Conclusion: In sites with 3–5 mm of RBH, SM‐TSFE provides implant survival rates comparable to LSFE over the observation period but offers a significant safety advantage due to a substantially lower rate of sinus membrane perforation.
- 21 April 2026
- Published by Wiley in Clinical Implant Dentistry and Related Research
- Vol. 28 (2) , e70150
Stepwise Modified Transcrestal Sinus Floor Elevation in Sites With 3–5‐mm Residual Bone Height: A Retrospective Study
Objectives: This retrospective study compared the clinical and radiographic outcomes of a stepwise modified transcrestal sinus floor elevation (SM‐TSFE) with the lateral sinus floor elevation (LSFE) for simultaneous implant placement in sites with 3–5 mm of residual bone height (RBH). Materials and Methods: A total of 149 patients with 3–5‐mm RBH underwent simultaneous implant placement using either SM‐TSFE ( n = 69) or LSFE ( n = 80). The follow‐up period ranged from 6 months to 8 years. Evaluated clinical outcomes included implant survival rates, sinus membrane perforation, and postoperative complications. Radiographic assessments included preoperative RBH, marginal bone loss (MBL), and vertical bone height changes. Results: Cumulative implant survival rates were comparable between SM‐TSFE (91.30%) and LSFE (93.75%) groups ( p = 0.537). However, the SM‐TSFE group demonstrated a significantly lower sinus membrane perforation rate (7.24%) compared to the LSFE group (18.75%; p = 0.047). Multivariate analysis identified maxillary sinus septa as the strongest risk factor for perforation ( p = 0.002). Regarding implant failure, TiUnite surface ( p = 0.035) and membrane perforation ( p = 0.039) were significant risk factors, while higher marginal bone height (MBH) was identified as a protective factor ( p = 0.003). Both groups exhibited comparable MBL at 2 years post‐loading ( p > 0.05). Conclusion: In sites with 3–5 mm of RBH, SM‐TSFE provides implant survival rates comparable to LSFE over the observation period but offers a significant safety advantage due to a substantially lower rate of sinus membrane perforation.